Latest filing published 25 Mar 2026 for Abbott Laboratories. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Jacob A. Orville, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Exact Sciences Corp and Abbott Laboratories. In total, 23 filings cover trades dated from 14 February 2022 to 23 March 2026.
The open-market record consists of 3 sales worth €995k, with no purchase. Besides market trades, the filings include 4 share grants and 16 option exercises.
On 25 March 2026 came the latest disclosure, a share grant in Abbott Laboratories. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations